Name | Type | Posted | Actions |
|---|---|---|---|
Salient Characteristics Qiagen LIAISON QuantiFERON TB Gold Plus and Control.pdf | Sep 16, 2025 |
Reagents for detection of Mycobacterium Tuberculosis: Liaison QuantiFERON TB Gold Plus and LIAISON Control QuantiFERON TB Gold Plus
Contact and place of performance
Brittany Chartier
Tacoma, WA
USA
THIS NOTICE OF INTENT IS NOT A REQUEST FOR QUOTES. A DETERMINATION NOT TO COMPETE THE PROPOSED PROCUREMENT BASED UPON RESPONSES TOTHIS NOTICE IS SOLELY WITHIN THE DISCRETION OF THE GOVERNMENT. Medical Readiness Contracting Office - Pacific hereby provides notice of its intent to award a sole-source, firm fixed price contract under the authority of FAR 13.106-1(b)(1). As a result, the Government intends to award direc...
View moreThe attached salient characteristics detail the requirements of this anticipated contract action. Market Research has demonstrated that the intended awardee is the only business that is able to meet the requirements.
THIS NOTICE OF INTENT IS NOT A REQUEST FOR QUOTES; no solicitation or RFQ will be forthcoming.
Any firm that believes it can provide the stated supplies can provide supporting documents demonstrating their capabilities and certifications. Interested parties may identify their interest and capability to respond to this requirement no later than Wednesday, 17 September 2025 at 11:00 AM Pacific Time.
All documents submitted will not be returned. Responses received may be used for future acquisitions. All interested parties shall submit clear and convincing documentation demonstrating their capabilities to satisfy the requirements contained within the attached Statement of Work. The capability documentation should include general information and technical background describing in detail the prospective contractor's capabilities and experience that will demonstrate the ability to support these requirements.
Interested parties are encouraged to furnish information by email only with subject line stating - RESPONSE TO INTENT TO SOLE SOURCE FOR W81K0225QA107. Information can be sent to Brittany Chartier at [email protected]. No telephone or facsimile requests will be accepted. This procurement will be prepared in accordance with FAR Part 13, Simplified Acquisition Procedures.
Medical Readiness Contracting Office - Pacific will NOT be responsible for any costs incurred by interested parties in responding to this notice of intent. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
The Department of the Army, Medical Readiness Contracting Office - Pacific, has issued this combined synopsis and solicitation for the procurement of Liaison QuantiFERON-TB Gold Plus assay reagents and controls. These reagents are required for the detection of Mycobacterium tuberculosis immune responses via enzyme immunoassay at Madigan Army Medical Center in Tacoma, Washington. This requirement is categorized under NAICS 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. There is no set-aside associated with this notice.
The government intends to award a sole-source, firm-fixed-price indefinite delivery indefinite quantity (IDIQ) contract to Qiagen, LLC, for a five-year ordering period. The QuantiFERON-TB Gold Plus assays are the only FDA-cleared interferon-gamma release assays compatible with the facility's existing DiaSorin LIAISON XL analyzer. Utilizing these specific reagents ensures continuity of operations and maintains testing capacity without the need for additional instrumentation or physical workspace. Market research indicates that this awardee is the only business capable of meeting the government’s technical requirements.
While this notice of intent is not a request for quotes, interested firms may submit clear and convincing documentation of their capabilities and technical background by September 17, 2025. Responses must be submitted via email to Brittany Chartier under solicitation number W81K0225QA107. The procurement is being conducted in accordance with simplified acquisition procedures, and the government will use any received information to determine whether a competitive procurement is warranted. One attachment detailing salient characteristics was provided on September 16, 2025.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.